In pancreatic carcinoma and in melanoma, FOXP3 has a tumor-enhancing role through Treg and their effect on tumor tolerance [6, 7]; in ovarian, breast and prostate cancer, FOXP3 has a tumor-suppressing function [8, 9]. The gene discussed is FOXP3; the disease is exocrine pancreatic carcinoma.